C85.94 Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb

Name of the Condition

• Common Name: Non-Hodgkin Lymphoma
• Medical Term: Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb
• ICD Code: C85.94

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, part of the immune system. This code is used when the specific subtype of NHL is not clearly defined and the lymphoma is located in the lymph nodes of the axilla (armpit) or upper limb. The lymphatic system helps fight infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in the axilla or upper limb
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Persistent cough or chest discomfort
• Itching or skin rashes
• Difficulty moving the affected limb

Diagnosis

Diagnosis typically involves a combination of physical examination, blood tests, imaging scans (e.g., CT, MRI, PET), and a lymph node biopsy. A biopsy confirms the presence of cancerous lymphocytes and helps determine the subtype, though this code is used when the subtype is unspecified. Additional tests, such as bone marrow biopsy or flow cytometry, may be performed to assess the extent of the disease.

Treatment Options

• Chemotherapy: Uses drugs to destroy cancer cells, often the primary treatment for NHL.
• Radiation therapy: Targets localized lymphoma in the axilla or upper limb to reduce tumor size.
• Immunotherapy: Boosts the immune system to fight cancer cells.
• Targeted therapy: Uses drugs to target specific cancer cell characteristics.
• Stem cell transplant: Replaces damaged bone marrow with healthy cells, typically for advanced cases.

Prognosis and Follow-Up

Prognosis depends on factors like the subtype, stage, and overall health. Early detection and treatment improve outcomes. Follow-up care includes regular monitoring for recurrence, imaging scans, and blood tests. Long-term survivors may require ongoing surveillance for late effects of treatment.

Complications

• Recurrence of lymphoma
• Infection due to weakened immune system
• Side effects from treatment (e.g., fatigue, nausea, organ damage)
• Lymphedema (swelling) in the affected limb
• Secondary cancers from chemotherapy or radiation

Lifestyle & Prevention

• Maintain a healthy immune system through balanced diet and regular exercise.
• Avoid exposure to known carcinogens (e.g., pesticides, tobacco).
• Manage chronic infections or immune disorders with medical care.
• Stay up-to-date with vaccinations to reduce infection risk.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or fatigue. Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

Use this code when the lymphoma is located in the lymph nodes of the axilla or upper limb and the subtype is unspecified. Ensure documentation supports the anatomical site and lack of subtype specification. Verify that more specific codes (e.g., for defined subtypes) are not applicable before assigning C85.94.